Company: VSA
Filing Date: 2025-11-20
Form Type: 6-K
Source: 0001213900-25-112849
Chunk: 0

Company: VisionSys AI Inc
Filing Date: 2025-11-20
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-36363

VISIONSYS AI INC

2 Hammarskjold Plaza, Room 10B

2nd Avenue, New York, NY 10017

Tel: +1 (929) 687-0368

(Address of Principal Executive Offices)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F☒Form 40-F☐</div>

Registered Direct Offering

On November 11, 2025, VisionSys
AI Inc (the “Company”) entered into certain securities purchase agreement (the “Purchase Agreement”)
with certain non-affiliated institutional investors (the “Purchasers”) pursuant to which the Company agreed to sell
9,230,750 American Depositary Shares (“ADS”) and accompanying series A warrants to purchase up to 9,230,750 ADSs (the
“Series A Warrants”) in a registered direct offering. The combined effective offering price for each ADS and the accompanying
Series A Warrant is $1.30 (the “Offering Price”). The gross proceeds to the Company from the registered direct offering
are approximately $12.0 million before deducting the placement agent’s fees and other estimated offering expenses.

Each Warrant is immediately
exercisable, will expire five years from the initial exercise date and have an exercise price of $1.30 per ADS, subject to adjustment
of the exercise price to $0.91 on the First Reset Date and to $0.65 on the Second Reset Date (each as defined in the Series A Warrants)
and subject to a floor price therein. The Series A Warrants may also be exercised on a zero cash exercise option pursuant to which the
holder may exchange each warrant for three ADSs.

The Company agreed in the
Purchase Agreement that it and its subsidiaries would not issue, enter into any agreement to issue or announce the issuance or proposed
issuance of any ADSs, Class A ordinary shares, or Ordinary Share Equivalents(as